La difusión de los procesos de aprendizaje de los estudiantes de Bellas Artes mediante el empleo de estrategias de visibilidad y difusión a partir de técnicas del diseño gráfico

Memoria ID-120. Ayudas de la Universidad de Salamanca para la innovación docente, curso 2019-2020.[ES]El proyecto propone un trasvase coordinado y aplicación de contenidos de unas asignaturas en otras, con el objetivo global de estimular la creatividad del estudiante mediante una serie de actividades extraacadémicas, a través del Diseño gráfico, conjugando herramientas desde las áreas de Pintura, Dibujo, Escultura e Historia del Art

A facility and community-based assessment of scabies in rural Malawi.

Background Scabies is a neglected tropical disease of the skin, causing severe itching, stigmatizing skin lesions and systemic complications. Since 2015, the DerMalawi project provide an integrated skin diseases clinics and Tele-dermatology care in Malawi. Clinic based data suggested a progressive increase in scabies cases observed. To better identify and treat individuals with scabies in the region, we shifted from a clinic-based model to a community based outreach programme. Methodology/principal findings From May 2015, DerMalawi project provide integrated skin diseases and Tele-dermatological care in the Nkhotakota and Salima health districts in Malawi. Demographic and clinical data of all patients personally attended are recorded. Due to a progressive increase in the number of cases of scabies the project shifted to a community-based outreach programme. For the community outreach activities, we conducted three visits between 2018 to 2019 and undertook screening in schools and villages of Alinafe Hospital catchment area. Treatment was offered for all the cases and school or household contacts. Scabies increased from 2.9% to 39.2% of all cases seen by the DerMalawi project at clinics between 2015 to 2018. During the community-based activities approximately 50% of the population was assessed in each of three visits. The prevalence of scabies was similar in the first two rounds, 15.4% (2392) at the first visit and 17.2% at the second visit. The prevalence of scabies appeared to be lower (2.4%) at the third visit. The prevalence of impetigo appeared unchanged and was 6.7% at the first visit and 5.2% at the final visit. Conclusions/significance Prevalence of scabies in our setting was very high suggesting that scabies is a major public health problem in parts of Malawi. Further work is required to more accurately assess the burden of disease and develop appropriate public health strategies for its control

Modelo para determinar la cuota en tienda de un producto en el punto de venta

La elaboración de modelos de marketing ha sido una labor emprendida por distintos autores que comienza en la década de los 60 y llega hasta la actualidad. Sin embargo la mayor parte de estos modelos, han pasado desapercibidos para los profesionales del marketing. El objetivo fundamental de esta tesis es construir un modelo de marketing que determine que variables, propias y de la competencia, son las que influyen en la cuota en tienda de una marca. Para lograr el objetivo, se ha comenzado, en primer lugar, por revisar las aportaciones realizadas en el área de los modelos de marketing. En segundo lugar se ha realizado una clasificación de los modelos, para ubicar mejor al modelo objeto de esta tesis. La metodología para construir el modelo ha venido determinada por el tipo de dato disponible. Los datos utilizados han sido proporcionados por Nielsen. Son datos agregados que muestran la evolución en el tiempo de diferentes magnitudes de marketing. Esta agregación puede realizarse por formato y/o por tipo de establecimiento. La primera cuestión a contestar es: ¿Existe un modelo para cada establecimiento/formato o por el contrario un modelo único y global? Un modelo único, supone aceptar una realidad comercial idéntica independientemente del formato y/o el establecimiento; una realidad demasiado simple. La alternativa es admitir un modelo diferente para cada formato y establecimiento; una realidad compleja, que implica una mayor dificultad para analizar la realidad comercial..

A tale of five stories: Defence spending and economic growth in NATO´s countries.

This article examines the relationship between defence expenditure and its impact on the growth of NATO's countries between 2005 and 2018. The aim is to determine if this relation exists and to test if it is possible to discover different models across the countries. The results obtained using the Arellano-Bond estimator, suggest that there is more than one model, and confirm, through the poolability test, the existence of five different groups of countries within the Alliance, with different impacts of the defence expenditure on their gross domestic product. These findings are in line with the review of existing literature that reveals heterogeneity in the results due to different parameters used

Revista de educación

Resumen basado en el de la publicaciónEn la Comunidad de Madrid el porcentaje de familias que optan por la enseñanza de pago es muy superior en comparación con el resto de comunidades autónomas. El objetivo es ofrecer una visión de las características de los hogares que demandan este tipo de enseñanza, así como analizar el efecto que la actual crisis económica ha tenido en las decisiones de las familias madrileñas en cuanto al gasto en la educación de sus hijos. Las principales fuentes de información empleadas han sido la Encuesta de Presupuestos Familiares, elaborada por el Instituto Nacional de Estadística, y diversas estadísticas publicadas por el Ministerio de Educación, Cultura y Deporte y por la Consejería de Educación de la Comunidad Autónoma de Madrid. Se comprueba que la crisis económica no ha hecho que las familias madrileñas reduzcan fuertemente sus gastos en materia de enseñanza, sino que estos han caído en menor medida que el gasto medio en el resto de conceptos. Concluye que la enseñanza privada también está presente en hogares con menores ingresos.ES

Patients attended: Scabies, Impetigo and demographic data

A dataset that contains information on patients who received a facility or community-based assessment of Scabies . It contains six variables – age, gender, scabies assessment status, impetigo assessment status, site location, and treatment round number. Data was collected by the DerMalawi project through integrated skin diseases clinics and Tele-dermatology care that they established in 2015 in the Nkhotakota and Salima health districts in Malawi

A facility and community-based assessment of scabies in rural malawi

Altres ajuts: CantabriaLabs; Martiderm; Italfarmaco; Fundación CSAI; Ayuntamiento de Villanueva de la Cañada; Spanish Academy of Dermatology (CG); Colegio Oficial de Médicos de Madrid (CG); Fundación Mutua Madrileña (CG); Celia Delgado Matías Association; Universidad de Salamanca.Background Scabies is a neglected tropical disease of the skin, causing severe itching, stigmatizing skin lesions and systemic complications. Since 2015, the DerMalawi project provide an integrated skin diseases clinics and Tele-dermatology care in Malawi. Clinic based data suggested a progressive increase in scabies cases observed. To better identify and treat individuals with scabies in the region, we shifted from a clinic-based model to a community based outreach programme. Methodology/Principal findings From May 2015, DerMalawi project provide integrated skin diseases and Tele-dermatologi-cal care in the Nkhotakota and Salima health districts in Malawi. Demographic and clinical data of all patients personally attended are recorded. Due to a progressive increase in the number of cases of scabies the project shifted to a community-based outreach programme. For the community outreach activities, we conducted three visits between 2018 to 2019 and undertook screening in schools and villages of Alinafe Hospital catchment area. Treatment was offered for all the cases and school or household contacts. Scabies increased from 2.9% to 39.2% of all cases seen by the DerMalawi project at clinics between 2015 to 2018. During the community-based activities approximately 50% of the population was assessed in each of three visits. The prevalence of scabies was similar in the first two rounds, 15.4% (2392) at the first visit and 17.2% at the second visit. The prevalence of scabies appeared to be lower (2.4%) at the third visit. The prevalence of impetigo appeared unchanged and was 6.7% at the first visit and 5.2% at the final visit. Conclusions/Significance Prevalence of scabies in our setting was very high suggesting that scabies is a major public health problem in parts of Malawi. Further work is required to more accurately assess the burden of disease and develop appropriate public health strategies for its control

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trialResearch in context

Summary: Background: Anti-COVID-19 hyperimmune immunoglobulin (hIG) can provide standardized and controlled antibody content. Data from controlled clinical trials using hIG for the prevention or treatment of COVID-19 outpatients have not been reported. We assessed the safety and efficacy of subcutaneous anti-COVID-19 hyperimmune immunoglobulin 20% (C19-IG20%) compared to placebo in preventing development of symptomatic COVID-19 in asymptomatic individuals with SARS-CoV-2 infection. Methods: We did a multicentre, randomized, double-blind, placebo-controlled trial, in asymptomatic unvaccinated adults (≥18 years of age) with confirmed SARS-CoV-2 infection within 5 days between April 28 and December 27, 2021. Participants were randomly assigned (1:1:1) to receive a blinded subcutaneous infusion of 10 mL with 1 g or 2 g of C19-IG20%, or an equivalent volume of saline as placebo. The primary endpoint was the proportion of participants who remained asymptomatic through day 14 after infusion. Secondary endpoints included the proportion of individuals who required oxygen supplementation, any medically attended visit, hospitalisation, or ICU, and viral load reduction and viral clearance in nasopharyngeal swabs. Safety was assessed as the proportion of patients with adverse events. The trial was terminated early due to a lack of potential benefit in the target population in a planned interim analysis conducted in December 2021. ClinicalTrials.gov registry: NCT04847141. Findings: 461 individuals (mean age 39.6 years [SD 12.8]) were randomized and received the intervention within a mean of 3.1 (SD 1.27) days from a positive SARS-CoV-2 test. In the prespecified modified intention-to-treat analysis that included only participants who received a subcutaneous infusion, the primary outcome occurred in 59.9% (91/152) of participants receiving 1 g C19-IG20%, 64.7% (99/153) receiving 2 g, and 63.5% (99/156) receiving placebo (difference in proportions 1 g C19-IG20% vs. placebo, −3.6%; 95% CI -14.6% to 7.3%, p = 0.53; 2 g C19-IG20% vs placebo, 1.1%; −9.6% to 11.9%, p = 0.85). None of the secondary clinical efficacy endpoints or virological endpoints were significantly different between study groups. Adverse event rate was similar between groups, and no severe or life-threatening adverse events related to investigational product infusion were reported. Interpretation: Our findings suggested that administration of subcutaneous human hyperimmune immunoglobulin C19-IG20% to asymptomatic individuals with SARS-CoV-2 infection was safe but did not prevent development of symptomatic COVID-19. Funding: Grifols